Delaware made a big bet on the WuXi STA pharmaceutical campus in Middletown — $500 million in investment, hundreds of good-paying jobs, and a real chance to put our state at the center of American drug manufacturing. I was proud of that vision. But the Pentagon just added WuXi AppTec's subsidiary to its official list of companies it considers connected to the Chinese military. That changes things, and I don't think Delaware families should be left in the dark about what it means for our money and our community.
This isn't a small footnote. That federal designation has already triggered restrictions under the BIOSECURE Act, which is moving through Congress and would bar federal contracts with companies on that list. If the Middletown facility can't work with federal partners — and most large pharmaceutical operations do — the entire project could be in serious trouble before a single pill gets made here. We could be looking at a facility that sits half-finished, jobs that never materialize, and a economic development story that becomes a cautionary tale instead of a success.
I'm asking you to call for an immediate, transparent review of the state's investment in the WuXi Middletown campus in light of this Pentagon designation — and to share what you find with constituents before any more public resources are committed.
Please demand a clear public accounting of what Delaware stands to lose, and make sure our state isn't doubling down on a deal that federal law may make impossible to complete.
---
